Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study

Thomas Urup, W Z Pawlak, P M Petersen, H Pappot, M Rørth, G Daugaard

    22 Citationer (Scopus)

    Abstract

    Adrenocortical carcinoma (ACC) is a rare disease with a poor response to chemotherapy. Cisplatin is the most widely investigated drug in the treatment of ACC and in vitro studies have indicated activity of taxanes. The objectives of this study were to evaluate the efficacy and toxicity of cisplatin combined with docetaxel as first-line treatment of advanced ACC.
    OriginalsprogEngelsk
    TidsskriftB J C
    Vol/bind108
    Udgave nummer10
    Sider (fra-til)1994-7
    Antal sider4
    ISSN0007-0920
    DOI
    StatusUdgivet - 28 maj 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study'. Sammen danner de et unikt fingeraftryk.

    Citationsformater